GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: GSK839 is a selective inhibitor of Mycobacterium tuberculosis tryptophan synthase (TrpAB) that is in preclinical evaluation for the treatment of tuberculosis. It is one of the compounds claimed by GlaxoSmithKline in patent WO2019034729A1 [1].
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| 4-[2-[(5-fluoropyridin-2-yl)methyl]tetrazol-5-yl]-N-(2-hydroxyethyl)benzenesulfonamide |
Database Links ![]() |
|
| Specialist databases | |
Antibiotic DB
|
GSK839 |
| Other databases | |
| CAS Registry No. | 2284580-65-8 (source: Scifinder) |
| ChEMBL Ligand | CHEMBL5203958 |
| GtoPdb PubChem SID | 513757640 |
| PubChem CID | 137499806 |
| Search Google for chemical match using the InChIKey | ZADGDPAVPJLDBU-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | ZADGDPAVPJLDBU |
| UniChem Compound Search for chemical match using the InChIKey | ZADGDPAVPJLDBU-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | ZADGDPAVPJLDBU-UHFFFAOYSA-N |